Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.19 USD | -2.56% | -5.84% | +152.41% |
May. 07 | HC Wainwright Adjusts Price Target on ADC Therapeutics to $8 From $9, Maintains Buy Rating | MT |
May. 06 | Rate Cut Hopes Lift Exchange-Traded Funds, Equity Futures Pre-Bell Monday | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+152.41% | 403M | |
+5.66% | 111B | |
+11.23% | 105B | |
-2.30% | 21.93B | |
-12.15% | 22.34B | |
-5.66% | 18.59B | |
-36.52% | 18.12B | |
-10.09% | 16.96B | |
+3.33% | 13.7B | |
+36.58% | 12.45B |
- Stock Market
- Equities
- ADCT Stock
- News ADC Therapeutics SA
- ADC Therapeutics' Joint Venture Doses First Patient in Phase 3 Trial of Lymphoma Drug Candidate Zynlonta